and accurate determination of pharmaceutical equivalence of drugs in pharmaceutical dosage-form, and may be used as a technique for testing generic antibiotics prior to their approval for human use.

Apply to Canada's #1 comprehensive university and see yourself joining the SFU community! Whether you're a high school student or a transfer student from another post-secondary institution, follow ...

This is the legal requirement for your application to be considered “signed” according to Canada’s immigration law. You’ll fill out these digital forms inside the portal (for yourself, and any family ...

But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Here’s more about this ...

It also looks at costs, including generic brand options ... Anticoagulants thin the blood, making it take longer to form a clot and thereby reducing the risk of blood clots in common conditions ...

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and Valsartan tablets for heart failure patients. Sacubitril and Valsartan ...

Prime Minister Justin Trudeau said on Tuesday that Canada will hit back at the U.S. if President Donald Trump goes ahead with punishing tariffs on Feb. 1, promising this country will respond in ...

Canada’s population will grow over the years regardless of the federal government’s recent decision to slash immigration rates, a new report shows. Statistics Canada released new projection ...

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...

teenager with brain cancer and her family will have to travel to the United States to receive a cutting edge form of radiation therapy that's not yet available anywhere in Canada. Hailey ...

The U.S. Court of Appeals for the Federal Circuit ordered MSN not to launch its drug, opens new tab while it considers Novartis' request for a longer ban on the generic version. The decision marks ...